Application of phosphogypsum and phosphate-solubilizing fungi to Pb remediation: From simulation to in vivo incubation.

Phosphogypsum (PG) is the produced solid waste during phosphorus (P) extraction from phosphate rocks. PG is featured by its abundant PO43- and SO42-. This study investigated the utilization of PG as a material for lead (Pb) remediation, with the assistance of functional fungus. Aspergillus niger (A. niger) is a typical phosphate-solubilizing fungi (PSF), which has high ability to secret organic acids. Oxalic acid is its major secreted organic acid, which is often applied to enhance the P release from phosphate minerals. In this study, synthetic oxalic acid increased the immobilization rate of Pb2+ up to >99 % with the addition of PG. Then, it was observed that biogenic oxalic acid from A. niger can achieve comparable remediation effects. This was due to that PG could provide sufficient P for fungal growth, which allowed sustainable remediation. Subsequently, oxalic acid secreted by A. niger significantly increased the release of active P from PG, and then induced the formation of PPb minerals. In addition, other metabolites of A. niger (such as tyrosine-like substance) can also be complexed with Pb2+. Simultaneously, A. niger did not induce evidently elevation water-soluble fluorine (F) as PG contained abundant Ca2+. Moreover, this study elucidated that oversupply of PG promoted the formation of anglesite (Ksp = 1.6 × 10-8, relatively unstable), whereas the formation of lead oxalate (Ksp = 4.8 × 10-10, relatively stable) was reduced. This study hence shed a bright light on the sustainable utilization of PG for fungus-assisted remediation of heavy metals.

Towards sustainable development: what carbon trading pilot policy has been done for mitigating carbon emissions and air pollution?

This study examines the impact of carbon trading pilot policy (CTPP) on carbon emissions (CO2) and air pollution (Ap) using the difference in differences method (DID) utilizing panel data from 30 Chinese areas spanning from 2008 to 2020. The results indicate that CTPP implementation can effectively decrease CO2 and Ap. CTPP can reduce CO2 and Ap through positive incentive effects that promote industrial structure upgrading and drive technological progress. Moreover, CTPP exhibits significant regional variation, with CTPP significantly reducing CO2 in both the eastern and central and western regions. CTPP do not show an effective reduction in Ap in eastern region, while effectively reduce Ap in central and western regions.

The drivers of carbon emissions in China: the perspective of fiscal decentralization.

Fiscal decentralization determines government behavior considerably by being a major factor influencing China's carbon emissions. We analyze the impact of fiscal decentralization on carbon emissions on basis of the dataset of 30 Chinese areas for the period 2008 to 2020. We reveal that fiscal decentralization significantly raises carbon emissions, but worsens carbon emission efficiency. The impact of fiscal decentralization on carbon emissions varies significantly by geographical location and economic development level shocks. Local governments increase the expenditure on economic services while reducing the expenditure on basic public services as a result of the fiscal decentralization scheme, which is an important reason why the carbon emission level cannot be effectively improved. As such, it is necessary to keep pace with the times, and build a service-oriented government, and capitalize on the capabilities of local governments in terms of their service duties so as to maximize carbon reduction.

Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy.

Cancer immunotherapy effect can be greatly enhanced by other methods to induce immunogenic cell death (ICD), which has profoundly affected immunotherapy as a highly efficient paradigm. However, these treatments have significant limitations, either by causing damage of the immune system or limited to superficial tumors. Sonodynamic therapy (SDT) can induce ICD to promote immunotherapy without affecting the immune system because of its excellent spatiotemporal selectivity and low side effects. Nevertheless, SDT is still limited by low reactive oxygen species yield and the complex tumor microenvironment. Recently, some emerging SDT-based nanomedicines have made numerous attractive and encouraging achievements in the field of cancer immunotherapy due to high immunotherapeutic efficiency. However, this cross-cutting field of research is still far from being widely explored due to huge professional barriers. Herein, the characteristics of the tumor immune microenvironment and the mechanisms of ICD are firstly systematically summarized. Subsequently, the therapeutic mechanism of SDT is fully summarized, and the advantages and limitations of SDT are discussed. The representative advances of SDT-based nanomedicines for cancer immunotherapy are further highlighted. Finally, the application prospects and challenges of SDT-based immunotherapy in future clinical translation are discussed.

State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC.

Liver models are vital for the liver diseases and drug research as many novel drugs. However, traditional liver models cannot meet this need, mainly because they cannot replicate the complex physiological structure and microenvironment of the liver, especially the O2 and nutrient gradients. Liver-on-a-chip (LOC), based on microfluidic technology, can not only closely simulate the physiological structure and microenvironment of the liver through the design of suitable microchannels, but can also incorporate advanced biosensors with high sensitivity and potential for rapid responses to microenvironmental signals and liver function indicators. Nevertheless, LOCs have not been widely exploited for liver disease research or the screening of drugs for hepatotoxicity because of considerable professional barriers. In this review, we comprehensively summarize recent progress in LOC development and the embedding of biosensors into LOCs. We first introduce the physiological characteristics and microenvironment of the liver and then summarize the fabrication process and advantages of LOCs. We subsequently focus on recent advances relating to three-dimensional (3D) hepatocyte organization and the simulation of hepatic sinusoids and lobules in LOCs and further systematically summarize the research progress in biosensor-integrated LOCs. Finally, we discuss the potential value of LOCs and the challenges facing their exploitation. In conclusion, this review provides insights into the design and development of biosensor-integrated LOCs aiming to promote further research into this promising platform.

Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC.

Immunotherapy has revolutionized cancer treatment, dramatically improving survival rates of melanoma and lung cancer patients. Nevertheless, immunotherapy is almost ineffective against ovarian cancer (OC) due to its cold tumor immune microenvironment (TIM). Many traditional medications aimed at remodeling TIM are often associated with severe systemic toxicity, require frequent dosing, and show only modest clinical efficacy. In recent years, emerging nanomedicines have demonstrated extraordinary immunotherapeutic effects for OC by reversing the TIM because the physical and biochemical features of nanomedicines can all be harnessed to obtain optimal and expected tissue distribution and cellular uptake. However, nanomedicines are far from being widely explored in the field of OC immunotherapy due to the lack of appreciation for the professional barriers of nanomedicine and pathology, limiting the horizons of biomedical researchers and materials scientists. Herein, a typical cold tumor-OC is adopted as a paradigm to introduce the classification of TIM, the TIM characteristics of OC, and the advantages of nanomedicines for immunotherapy. Subsequently, current nanomedicines are comprehensively summarized through five general strategies to substantially enhance the efficacy of immunotherapy by heating the cold OC. Finally, the challenges and perspectives of this expanding field for improved development of clinical applications are also discussed.

Nanodrugs Manipulating Endoplasmic Reticulum Stress for Highly Effective Antitumor Therapy.

Cancer is one of the leading causes of death worldwide due to high morbidity and mortality. Many attempts and efforts have been devoted to fighting cancer. Owing to the significant role of the endoplasmic reticulum (ER) in cell function, inducing ER stress can be promising for cancer treatment. However, the sustained activation of cytoprotective unfolded protein response (UPR) presents a tremendous obstacle for drugs in inducing unsolved ER stress in tumor cells, especially small-molecule drugs with poor bioavailability. Therefore, many emerging nanodrugs inducing and amplifying ER stress have been developed for efficient cancer treatment. More importantly, the novel discovery of ER stress in immunogenic cell death (ICD) makes it possible to repurpose antitumor drugs for immunotherapy through nanodrug-based strategies amplifying ER stress. Therefore, this mini-review aims to provide a comprehensive summary of the latest developments of the strategies underlying nanodrugs in the treatment of cancer via manipulating ER stress. Meanwhile, the prospects of ER stress-inducing nanodrugs for cancer treatment are systematically discussed, which provide a sound platform for novel therapeutic insights and inspiration for the design of nanodrugs in treating cancer.

[Clinical application of titanium ossicular prostheses in intact canal wall tympanoplasty with mastoidectomy].

OBJECTIVE: To evaluate the effects of intact canal wall tympanoplasty with mastoidectomy (ICWT) with titanium ossicular prostheses. METHOD: A retrospective review was performed on 31 patients who underwent ICWT from 2008 to 2011. Patients' postoperative hearing results and complication rates were evaluated based on different types of ossicular prosthesis: partial ossicular replacement prosthesis (PORP), total ossicular replacement prosthesis (TORP). RESULT: The total effectiveness was 87.1%. No prosthesis was extruded. There was no significant difference in postoperative hearing results (average postoperative gain and ABG) between the two prostheses. In the low frequency (0.5 kHz), significant difference in ABG was found. CONCLUSION: No significant difference in postoperative hearing results was found between PORP and TORP, which could be useful materials for tympanoplasty and obviously improve the hearing of otitis media patients after operation. As for the low incidence of postoperative complications in our short-term study, long-term follow-up visit is necessary.